Intravenous immunoglobulins in the third millennium:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Boca Raton [u.a.]
Parthenon Publ. Group
2004
|
| Ausgabe: | 1. publ. |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | Includes bibliographical references and index |
| Beschreibung: | XX, 420 S. graph. Darst. |
| ISBN: | 1842142585 |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV017828191 | ||
| 003 | DE-604 | ||
| 005 | 20061127 | ||
| 007 | t | ||
| 008 | 040203s2004 xxud||| |||| 00||| eng d | ||
| 010 | |a 2004040032 | ||
| 020 | |a 1842142585 |9 1-84214-258-5 | ||
| 035 | |a (OCoLC)54029446 | ||
| 035 | |a (DE-599)BVBBV017828191 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c US | ||
| 049 | |a DE-19 |a DE-29 | ||
| 050 | 0 | |a RM282.I44 | |
| 082 | 0 | |a 615/.37 |2 22 | |
| 245 | 1 | 0 | |a Intravenous immunoglobulins in the third millennium |c ed. by Marinos C. Dalakas ... |
| 250 | |a 1. publ. | ||
| 264 | 1 | |a Boca Raton [u.a.] |b Parthenon Publ. Group |c 2004 | |
| 300 | |a XX, 420 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a Includes bibliographical references and index | ||
| 650 | 4 | |a Immunoglobulins |x Therapeutic use | |
| 650 | 4 | |a Immunoglobulins, Intravenous |x therapeutic use | |
| 650 | 0 | 7 | |a Immunglobuline |0 (DE-588)4026626-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Intravenöse Applikation |0 (DE-588)4525889-2 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Immunglobuline |0 (DE-588)4026626-6 |D s |
| 689 | 0 | 1 | |a Intravenöse Applikation |0 (DE-588)4525889-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Dalakas, Marinos C. |e Sonstige |4 oth | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=010701545&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-010701545 | ||
Datensatz im Suchindex
| _version_ | 1804130516373340160 |
|---|---|
| adam_text | Contents
List of speakers and chairpersons xi
Foreword xix
Two decades of experience with intravenous immunoglobulin 1
1. Manufacturing of intravenous immunoglobulin: challenges, 3
achievements and opportunities
A. Morell
2. Challenges and achievements in pathogen safety of intravenous immunoglobulin 9
P.J. Spdth and C. Kempf
3. Treatment modalities and clinical efficacy of immunoglobulin G replacement 21
therapies in primary immunodeficiency
A. D. B. Webster
4. Immunomodulation by intravenous immunoglobulin: idiopathic 29
thrombocytopenic purpura as a model
P. Imbach
5. Witnessing the introduction and use of intravenous immunoglobulin in neurology 37
M. C. Dalakas
6. Pharmacoeconomics of intravenous immunoglobulin administration in 41
neurological disorders: the US experience
P. D. Donofrio
V
7. Pharmacoeconomics of intravenous immunoglobulin for polyneuropathies 47
P. McCrone
Intravenous immunoglobulin in immunodeficiencies and severe 51
infections molecular aspects and clinical use
8. B cell maturation to produce high affinity antibodies of different isotypes 53
and its abnormalities
A. Durandy
9 The molecular basis of primary immune deficiency diseases 57
H. D. Ochs, T. R. Torgerson, W. I. Lee, Y. Z.Jin, E. Gambineri and Q. Zhu
10. Safety in intravenous immunoglobulin therapy 71
E. W. Gelfand
11. Immunoglobulin replacement by the subcutaneous route using preparations 77
licensed in the USA for administration by other routes
M. Berger, K. DuffJ. Poll and S. Roy
12. The use of intravenous immunoglobulin for allogeneic stem cell transplantation: 81
the US experience
R. H. Buckley
13. Intravenous immunoglobulin for bone marrow/stem cell transplantation: 85
the European experience
K. Theunissen, J. A. Maertens and M. A. Boogaerts
14. Secondary antibody deficiency following treatment of vasculitis: 91
the use of intravenous immunoglobulin
V.J Tormey and A. Burns
15. Intravenous immunoglobulin in the prevention and treatment of severe infections 95
K. Werdan
Immunomodulatory and anti inflammatory potential of 103
intravenous immunoglobulin
16. Mechanisms of action of intravenous immunoglobulin in autoimmune 105
and inflammatory diseases
M. D. Kazatchkine, J. Bayry, S. Lacroix Desmazes and S. V Kaveri
17. Role of intravenous immunoglobulin in reversing glucocorticoid 113
insensitivity or resistance
E. W. Gelfand
18. Modulating the balance of activating and inhibiting Fey receptors: 121
mechanism of intravenous immunoglobulin action
L. Pricop
19 Anti inflammatory effects of intravenous immunoglobulin: Fey receptor 127
inhibition/blockade and non Fey receptor mediated mechanisms
J. W. Semple and A. H. Lazarus
20. Immune modulation by intravenous immunoglobulin: some remarks on 133
the role of Fc receptors
E. van Mirre and C. E. Hack
21. Intravenous immunoglobulin in reactive hemophagocytic syndrome: 137
a paradigm of Fey receptor and cytokine modulation
L. Mouthon
22. Anti inflammatory effects of intravenous immunoglobulin through 143
modulation of complement activities
H. U. Lutz and P.J. Spath
23. Changes in gene expression profile in the muscles of patients with 149
dermatomyositis and inclusion body myositis after therapy with intravenous
immunoglobulin: a microarray analysis correlating gene expression with
clinical outcome
R. Raju and M. C. Dalakas
24. In vitro studies of mechanisms of action of intravenous immunoglobulin 153
in Guillain—Barre syndrome and Miller—Fisher syndrome: a review
R. Gold, A. Weishaupt, M. Stangel, A. Chan and K. V. Toyka
Intravenous immunoglobulin for autoimmune diseases of the 159
peripheral nervous system
25. The immunological rationale for intravenous immunoglobulin in Guillain Barre 161
syndrome and chronic inflammatory demyelinating polyradiculoneuropathy
J. D. Pollard
26. Intravenous immunoglobulin for Guillain—Barre syndrome and chronic 171
inflammatory demyelinating polyradiculoneuropathy in adult patients
P. A. van Doom
27. Clinical experience with intravenous immunoglobulin for treatment of pediatric 181
Guillain Barre syndrome and chronic inflammatory demyelinating
polyradiculoneuropathy
A.J. Kornberg
28. Intravenous immunoglobulin for multifocal motor neuropathy 187
L. H. van den Berg
29. Intravenous immunoglobulins in paraproteinemic demyelinating neuropathies 191
J. M. Leger
30. Immunoglobulins in IgM antimyelin associated glycoprotein and other 197
paraproteinemic neuropathies
G. Comi
31. Intravenous immunoglobulin for myasthenia gravis 203
P. Gajdos
32. Intravenous immunoglobulin in polymyositis and dermatomyositis 207
P. Cherin
33. Controlled studies with high dose intravenous immunoglobulin in the 213
treatment of inclusion body myositis
M. C. Dalakas
Intravenous immunoglobulin for autoimmune diseases of the 219
central nervous system
34. Immune mechanisms and treatment perspectives in multiple sclerosis 221
R. Hohlfeld
35. A review of controlled clinical trials of intravenous immunoglobulin in 229
multiple sclerosis
P. S. Sorensen
36. Intravenous immunoglobulin treatment for patients with primary or secondary 235
progressive multiple sclerosis
D. Pdhlau and U. Kallweit
37. What is the effective dose of intravenous immunoglobulin for treatment 243
of relapsing—remitting multiple sclerosis?
M. Lewanska, M. Siger Zajdel and K. Selmaj
38. High dose intravenous immunoglobulin in the treatment of patients with stiff 257
person syndrome: a controlled study
M. C. Dalakas
39. Intravenous immunoglobulin in acute disseminated encephalomyelitis 267
E. Marchioni, S. Ravaglia, A. Todeschini, A. Pichiecchio, C. Vggetti, G. Piccolo and M. Ceroni
The use of intravenous immunoglobulin in dermatology 277
40. Intravenous immunoglobulin in dermatology 279
S.Jolles
41. The use of intravenous immunoglobulin therapy in the treatment of 283
autoimmune mucocutaneous blistering diseases
A. R. Ahmed
42. Treatment of atopic dermatitis, urticaria and psoriasis with 291
intravenous immunoglobulin
M. Rustin
43. Intravenous immunoglobulin in toxic epidermal necrolysis and 297
Stevens—Johnson syndrome
L. E. French
AA. Intravenous immunoglobulin in the treatment of vasculitis 301
D. Jayne
Emerging applications for intravenous immunoglobulin 311
45. Immunomodulation by intravenous immunoglobulin of alloantibodies to 313
human leukocyte antigen: clinical aspects in solid organ transplantation
D. Glotz, C. Antoine, P.Julia, B. Pegaz Fiornet, A. Duboust, S. Boudjeltia, R. Fraoui,
M. Combes and]. Bariety
A6. Role of intravenous immunoglobulin in the management of heart failure 321
H. Krum
Al. Intravenous immunoglobulin: potential role in the management of 331
severe acute respiratory syndrome
H. H. Chng, K. P. Leong, B. Leung, B. Ang, Y S. Leo, S. Loo, S. K. Goh, T.W.K. Lew,
L. Y. Hsu, E. Ami and D. Tai
48. Enhancement of the immune response to Mycobacterium tuberculosis by 337
high dose intravenous immunoglobulin in mice
S. Jolles, E. Roy, V. Stavropoulos, S. Coade, E. Grigorieva, R. Tascon and D. Lowrie
Potential applications for intravenous immunoglobulin 341
49. Intravenous immunoglobulin for treatment of recurrent miscarriage 343
L. A. E. Noens
50. Epilepsy and the immune system: is there a link? 349
L. G. Lagae
51. Intravenous immunoglobulin as an immunomodulatory agent in 357
systemic lupus erythematosus and lupus nephritis
Y. Sherer and Y. Sboenfeld
52. Intravenous immunoglobulin for fibrosis, atherosclerosis and malignant conditions 361
/. Krause and Y. Shoenfeld
Summaries of poster sessions 367
53. Intravenous immunoglobulin for immune deficiencies and passive immunization 369
/. Quinti, M. Cagliuso and F. Aiuti
54. The use of intravenous immunoglobulin in hematology and transplantation 373
D. Provan
55. The use of intravenous immunoglobulin in neurology 377
W. K. Engel
56. The use of intravenous immunoglobulin for dermatological disorders 383
M. Sticherling
57. The use of intravenous immunoglobulin in collagen vascular and heart diseases 389
A. H. Lazarus
58. Intravenous immunoglobulin: mechanisms of action 393
P. E. Williams
59 Pathogen safety and tolerability of intravenous immunoglobulin 399
E Rossi
60. Pharmacoeconomics and evidence based medicine 405
G. Antonini and A. Di Pasquale
Index 409
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV017828191 |
| callnumber-first | R - Medicine |
| callnumber-label | RM282 |
| callnumber-raw | RM282.I44 |
| callnumber-search | RM282.I44 |
| callnumber-sort | RM 3282 I44 |
| callnumber-subject | RM - Therapeutics and Pharmacology |
| ctrlnum | (OCoLC)54029446 (DE-599)BVBBV017828191 |
| dewey-full | 615/.37 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.37 |
| dewey-search | 615/.37 |
| dewey-sort | 3615 237 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| edition | 1. publ. |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01651nam a2200433zc 4500</leader><controlfield tag="001">BV017828191</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20061127 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">040203s2004 xxud||| |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2004040032</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1842142585</subfield><subfield code="9">1-84214-258-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)54029446</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV017828191</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-29</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM282.I44</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.37</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Intravenous immunoglobulins in the third millennium</subfield><subfield code="c">ed. by Marinos C. Dalakas ...</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1. publ.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boca Raton [u.a.]</subfield><subfield code="b">Parthenon Publ. Group</subfield><subfield code="c">2004</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XX, 420 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunoglobulins</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunoglobulins, Intravenous</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Immunglobuline</subfield><subfield code="0">(DE-588)4026626-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Intravenöse Applikation</subfield><subfield code="0">(DE-588)4525889-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Immunglobuline</subfield><subfield code="0">(DE-588)4026626-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Intravenöse Applikation</subfield><subfield code="0">(DE-588)4525889-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dalakas, Marinos C.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=010701545&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-010701545</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV017828191 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T19:22:16Z |
| institution | BVB |
| isbn | 1842142585 |
| language | English |
| lccn | 2004040032 |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-010701545 |
| oclc_num | 54029446 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM DE-29 |
| owner_facet | DE-19 DE-BY-UBM DE-29 |
| physical | XX, 420 S. graph. Darst. |
| publishDate | 2004 |
| publishDateSearch | 2004 |
| publishDateSort | 2004 |
| publisher | Parthenon Publ. Group |
| record_format | marc |
| spelling | Intravenous immunoglobulins in the third millennium ed. by Marinos C. Dalakas ... 1. publ. Boca Raton [u.a.] Parthenon Publ. Group 2004 XX, 420 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Includes bibliographical references and index Immunoglobulins Therapeutic use Immunoglobulins, Intravenous therapeutic use Immunglobuline (DE-588)4026626-6 gnd rswk-swf Intravenöse Applikation (DE-588)4525889-2 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Immunglobuline (DE-588)4026626-6 s Intravenöse Applikation (DE-588)4525889-2 s DE-604 Dalakas, Marinos C. Sonstige oth HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=010701545&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Intravenous immunoglobulins in the third millennium Immunoglobulins Therapeutic use Immunoglobulins, Intravenous therapeutic use Immunglobuline (DE-588)4026626-6 gnd Intravenöse Applikation (DE-588)4525889-2 gnd |
| subject_GND | (DE-588)4026626-6 (DE-588)4525889-2 (DE-588)4143413-4 |
| title | Intravenous immunoglobulins in the third millennium |
| title_auth | Intravenous immunoglobulins in the third millennium |
| title_exact_search | Intravenous immunoglobulins in the third millennium |
| title_full | Intravenous immunoglobulins in the third millennium ed. by Marinos C. Dalakas ... |
| title_fullStr | Intravenous immunoglobulins in the third millennium ed. by Marinos C. Dalakas ... |
| title_full_unstemmed | Intravenous immunoglobulins in the third millennium ed. by Marinos C. Dalakas ... |
| title_short | Intravenous immunoglobulins in the third millennium |
| title_sort | intravenous immunoglobulins in the third millennium |
| topic | Immunoglobulins Therapeutic use Immunoglobulins, Intravenous therapeutic use Immunglobuline (DE-588)4026626-6 gnd Intravenöse Applikation (DE-588)4525889-2 gnd |
| topic_facet | Immunoglobulins Therapeutic use Immunoglobulins, Intravenous therapeutic use Immunglobuline Intravenöse Applikation Aufsatzsammlung |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=010701545&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT dalakasmarinosc intravenousimmunoglobulinsinthethirdmillennium |